By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Media HydeMedia Hyde
  • Home
  • Politics
  • Education
  • Entertainment
  • Sports
  • Blogs
  • Business & Commerce
  • Others
    • Religious
    • Metropolitan
    • Climate and Weather
Font ResizerAa
Media HydeMedia Hyde
Font ResizerAa
  • Home
  • Politics
  • Education
  • Entertainment
  • Sports
  • Blogs
  • Business & Commerce
  • Others
    • Religious
    • Metropolitan
    • Climate and Weather
Follow US
© 2026 Media Hyde Network. All Rights Reserved.
Health

COVID-19 Vaccine Protects Pregnant Women from Complications: Study

Last updated: December 20, 2025 8:27 am
Neha Ashraf
Share
SHARE

‎A new study has found that pregnant women who receive the COVID 19 vaccine have a lower risk of preterm birth.

‎The study, published in the Journal of the American Medical Association, also found that vaccination was associated with reduced chances of hospitalization or ICU admission among pregnant women.

‎Senior researcher of the study, Dr Debra Moomy, said that the findings show COVID 19 vaccination protects pregnant women and their babies from complications.

‎She said that although the virus continues to change its form, vaccination protects both the mother and the baby from complications.

‎According to the researchers, the study included outcomes from nearly 20,000 pregnancies in total.

Share This Article
Email Copy Link Print
Previous Article Possible Health Effects After Stopping Ozempic
Next Article Influenza Cases Rising Across the Country, What Are the Precautionary Measures?
Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Sponsored Ads

Stay Connected

FacebookLike
XFollow
InstagramFollow
YoutubeSubscribe
WhatsAppFollow
ThreadsFollow
Gold prices climb after three-day pause
Gold prices climb after three-day pause
Business & Commerce
September 30, 2026
Shaukat Yousafzai Warns of Possible Violence
PTI’s October 4 March: Shaukat Yousafzai Warns of Possible Violence
Breaking
September 29, 2026
C.T.E. Can’t Be Detected
New Research Offers Hope for Detecting CTE in Living People
Blog
September 29, 2026
Psychiatric Drugs
V.A. Institutes New Consent Requirements for Some Psychiatric Drugs
Breaking
September 29, 2026
Darshan Raval Announces New EP The Everafter, Reveals Four-Song Tracklist And Cover Art
Darshan Raval Announces New EP The Everafter, Reveals Four-Song Tracklist And Cover Art
Entertainment Headline
September 29, 2026
UAE confirms Netanyahu visit to Abu Dhabi
UAE confirms Netanyahu visit to Abu Dhabi
Headline Politics
September 29, 2026

You Might Also Like

WASHINGTON: UnitedHealth has warned that the Trump administration’s planned Medicare obesity-drug pilot faces “notable challenges,” casting doubt over how smoothly the program can move ahead if major insurers stay cautious. Recent market reporting said the model depends heavily on participation from Medicare drug plans that cover most Part D enrollees, which makes the stance of large insurers especially important. The concern centers on a broader CMS effort to expand access to GLP-1 weight-loss medicines for seniors. Under CMS’s published framework, the longer-term BALANCE Model would begin in Medicare Part D in January 2027, while a temporary Medicare GLP-1 Bridge is designed to start earlier and give eligible beneficiaries short-term access before that main model begins. What makes this a little more complicated is that the short-term bridge and the longer pilot are not the same thing. CMS says the Medicare GLP-1 Bridge operates outside the normal Part D coverage and payment flow, meaning Part D sponsors are not directly involved in that bridge arrangement. In other words, insurer participation is a much bigger issue for the 2027 BALANCE rollout than for the bridge itself. That distinction matters because investors and drugmakers are watching this closely. Reports said shares of obesity-drug makers fell after UnitedHealth’s comments, largely because Medicare coverage is seen as a huge growth opportunity for drugs such as Wegovy and Zepbound. If major insurers hesitate, the program could struggle to achieve the scale CMS appears to want. There is already some evidence of resistance. MarketWatch reported that CVS Health has opted out, while UnitedHealth is still evaluating the structure and discussing possible changes with Medicare officials. That does not mean the program is dead, not yet anyway, but it does suggest the administration may need to revise the design or sweeten the terms if it wants broader insurer buy-in. The bigger backdrop here is cost. Medicare has long been wary of broad obesity-drug coverage because GLP-1 therapies are expensive and potentially involve very large patient populations. Earlier policy debates around these drugs were shaped by concerns that wide coverage could drive up federal spending sharply, even as supporters argued the medicines could reduce longer-term health costs tied to obesity. So the headline problem for CMS is pretty straightforward: it has created a short-term bridge that can move without direct Part D plan involvement, but the more ambitious long-term Medicare model still appears to need insurers on board. UnitedHealth’s warning does not shut the door, but it does signal that one of the industry’s biggest players thinks the current setup may not be ready for easy launch.
HeadlineHealth

UnitedHealth raises red flags over Medicare obesity-drug pilot

By
Mabruka Khan
Health

Which is better for diabetic patients: coffee or tea?

By
Irma Khan
Health

Punjab Inaugurates its First Female Pathology Lab Collection Center at PIC

By
Irma Khan
Health

Vegetable Based Diet May Reduce Cancer Risks, Study Finds

By
Neha Ashraf
Media Hyde Media Hyde Dark
Facebook Twitter Youtube Rss Medium

About US

Media Hyde Network: Your instant connection to breaking stories and live updates. Stay informed with our real-time coverage across politics, tech, entertainment, and more. Your reliable source for 24/7 News.

Top Categories
  • Headline
  • Politics
  • Entertainment
  • Education
  • Sports
  • Religious
  • Metropolitan
  • Climate and Weather
Usefull Links
  • Contact Us
  • Disclaimer
  • Privacy Policy
  • Cookies Policy
  • Advertising Policy
  • Terms & Conditions

© 2025 Media Hyde Network. All Rights Reserved.

Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?